Form 4: Intuitive Surgical Executive Executes Stock Sale

Mark Brosius, EVP of Manufacturing and Supply Chain at Intuitive Surgical, sold 36 shares of common stock under a Rule 10b5-1 trading plan.

Summary

• Mark Brosius, EVP & Chief Manufacturing and Supply Chain Officer, sold a total of 36 shares of Intuitive Surgical (ISRG) common stock.
• The sales occurred on May 21, 2026 (18 shares at $446.04) and May 22, 2026 (18 shares at $439.80).
• The transactions were executed pursuant to a pre-established Rule 10b5-1 trading plan.
• Following these transactions, the reporting person retains beneficial ownership of 1,523 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the sale was executed via a pre-planned, automated trading program.

Positives

• The transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, which is designed to avoid concerns regarding insider trading.

Negatives

• The filing reflects a reduction in the executive's direct equity stake in the company.

Risks

• None identified in this specific filing.

Future Outlook

No forward-looking guidance provided in this filing.

Industry Context

StockSavvy.ai notes that routine executive stock sales under 10b5-1 plans are standard corporate practice and generally do not signal a change in company fundamentals or management sentiment.

Comparison to Industry Standards

• The use of Rule 10b5-1 plans is the industry standard for corporate executives to manage equity holdings while maintaining regulatory compliance.

Stakeholder Impact

• Minimal impact on shareholders as the transaction volume is negligible relative to the total outstanding shares.

Next Steps

• The reporting person will continue to execute trades under the existing 10b5-1 plan until its expiration on February 14, 2027.

Key Dates

Keywords

ISRG, Intuitive Surgical, Insider Trading, Form 4, Stock Sale, Executive Compensation